| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO2000016609A9 Novel method of regulating seed development in plants and genetic sequences therefor |
| 05/17/2001 | WO1999038972A9 Human genes and gene expression products ii |
| 05/17/2001 | WO1995002040A3 New stromal cell lines from human bone marrow and their use |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | DE19954514A1 Manipulating activity of cells ex vivo, useful e.g. in immunotherapy of cancer or viral infection, by treating the cells with antigens, adjuvants and stimulants |
| 05/17/2001 | DE19954376A1 Culturing of cells, particularly neuronal cells, useful for transplantation for treating neurological disorders such as Parkinson's disease or for gene therapy |
| 05/17/2001 | DE19953424A1 Cultivating, characterizing and separating multicellular spheroids in a reactor, employs balancing gravity to localize, select and collect specific sizes and densities |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391129A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | CA2391003A1 Chemical inducible promoters used to obtain transgenic plants with a silent marker |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390740A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390719A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2390568A1 Modification of polysaccharide containing materials |
| 05/17/2001 | CA2390504A1 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390011A1 Methods and compositions comprising renilla gfp |
| 05/17/2001 | CA2390008A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389722A1 15 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389506A1 Nucleic acid-containing complex |
| 05/17/2001 | CA2389488A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388829A1 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r2 |
| 05/17/2001 | CA2388755A1 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388019A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099754A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1098991A1 Novel methods for the identification of ligand and target biomolecules |
| 05/16/2001 | EP1098987A1 Method for transformation of animal cells |
| 05/16/2001 | EP1098986A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 05/16/2001 | EP1098984A2 Chorismate biosynthesis enzymes |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098976A2 Androgen receptor coactivators |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098973A1 Human lcb kinase 1 |
| 05/16/2001 | EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098969A2 Use of nucleic acid molecules as antiviral agents |
| 05/16/2001 | EP1098963A2 Chorismate synthase from plants |
| 05/16/2001 | EP1098962A2 Diacylglycerol acyl transferase proteins |
| 05/16/2001 | EP1098959A2 Medium and matrix for long-term proliferation of cells |
| 05/16/2001 | EP1098958A1 Method for providing a substrate structure for oriented neurite outgrowth, substrate structure, and device for monitoring neurons |
| 05/16/2001 | EP1098957A1 Transferring materials into cells using porous silicon |
| 05/16/2001 | EP1098909A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 05/16/2001 | EP1098908A2 Anti-ccr2 antibodies and methods of use therefor |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1011328A4 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 05/16/2001 | EP0994948B1 Tgf beta rii receptor nucleic sequence, coded peptide, and uses |
| 05/16/2001 | EP0927270A4 Lyophilization of cultured human cells to preserve rna and dna |
| 05/16/2001 | EP0847441B1 Apparatus and methods for culturing biological material |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | EP0753009B1 Malaria peptides |
| 05/16/2001 | CN1295622A Promoter inductible in plants, sequence incorporating same and resulting product |
| 05/16/2001 | CN1295621A Pathogen-inducible promoter |
| 05/16/2001 | CN1295619A Salicylate pathway gene and its use for induction of resistance in plants |
| 05/16/2001 | CN1295617A Variants of angiogenic factor vascular endothelial cell growth factor: VEGF |
| 05/16/2001 | CA2326057A1 Method for preparing biocompatible scaffold and scaffold prepared therefrom |
| 05/16/2001 | CA2324168A1 Antibody specific to interleukin 18 precursor |
| 05/15/2001 | US6232530 Marigold DNA encoding beta-cyclase |
| 05/15/2001 | US6232459 Synaptojanin isoform |
| 05/15/2001 | US6232457 Recombinant vanadium haloperoxidases and their uses |
| 05/15/2001 | US6232454 Nucleic acid and amino acid sequences and use in diagnosis, treatment, and prevention of cancer and immune disorders |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232448 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 05/15/2001 | US6232447 Antibody immunoreactive with a human cytokine designated LERK-6 |
| 05/15/2001 | US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders |
| 05/15/2001 | US6232441 PIGR-1, a member of immunoglobulin gene superfamily |
| 05/15/2001 | US6232292 3-dehydroquinate synthase |
| 05/15/2001 | US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors |
| 05/15/2001 | US6232122 Inhibition of gene expression |
| 05/15/2001 | US6232121 Methods for the production of biologically active agents contained in an extracellular matrix |
| 05/15/2001 | US6232120 Methods to inhibit replication of infective virus |
| 05/15/2001 | US6232119 Immortalized human fetal neuronal cell line |
| 05/15/2001 | US6232117 Expression vector wchich codes preferential controlling protein associated with transformation; for use as tool in genetic engineering |
| 05/15/2001 | US6232108 Prenylcysteine carboxyl methyltransferase, DNA encoding same, and a method of screening for inhibitors thereof |
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232105 Conditional replication and expression system |